Pure Bioscience FY 2026 Results: Net Loss of $2.48M, Loss Widens
PURE Bioscience, Inc. is focused on commercializing its proprietary Silver Dihydrogen Citrate (SDC) technology for food safety, including PURE Hard Surface and PURE Control. The company faces significant financial challenges, including a history of losses and a going concern warning from its auditors, necessitating additional capital to maintain operations.
- Key figure
- Net loss $2.48M